Table 1.
Reference | Country/society | AI population |
---|---|---|
Danziger-Isakov et al. [3] | USA/American Society of Transplantation (AST) | Solid organ transplant recipients |
Cordonnier et al. [4] | Multinational/from the European Conference on Infections in Leukaemia (ECIL) | HSCT |
Mikulska et al. [5] | Multinational/from the European Conference on Infections in Leukaemia (ECIL) | Patients with haematological disorders |
Martire et al. [6] | Italy/Italian Primary Immunodeficiencies Network (IPINET) | Multiple |
Lopez et al. [7] | France | Multiple |
Frésard et al. [8] | France | HIV-infected |
Rahier et al. [9] | Europe/European Crohn's and Colitis Organisation (ECCO) | Inflammatory bowel disease |
Rubin et al. [2] | USA/Infectious Diseases Society of America (IDSA) | Multiple |
Wasan et al. [10] | USA | Inflammatory bowel disease |
Davies et al. [12] | UK/British Committee for Standards in Haematology (BCSH) | Patients with asplenia |
Hilgendorf et al. [11] | Germany | HSCT |
Australian Department of Health | Australia/Updated 2020 | Multiple |
Government of Canada | Canada/Updated 2019 | Multiple |
CDC | USA/Advisory Committee on Immunization Practices (ACIP) Updated 2020 | Multiple |
HIV human immunodeficiency virus, HSCT haematopoietic stem cell transplant, CDC Centers for Infectious Disease Control and Prevention